title: [Indication and administration method in erythropoietin treatment].
authors.affiliation: Third Department of Internal Medicine, Ichihara Hospital, Teikyo University, School of Medicine.
authors.forename: K
authors.initials: K
authors.lastname: Koide
authors.forename: T
authors.initials: T
authors.lastname: Inumaru
authors.forename: T
authors.initials: T
authors.lastname: Arai
authors.forename: T
authors.initials: T
authors.lastname: Momose
authors.forename: F
authors.initials: F
authors.lastname: Takeda
authors.forename: K
authors.initials: K
authors.lastname: Matsuzaki
authors.forename: M
authors.initials: M
authors.lastname: Sano
mesh_terms: D000740:Anemia / Q000209:etiology / Q000628:therapy*; D004921:Erythropoietin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin